| hepatitis b, c and human immunodeficiency virus infections in multiply-injected kala-azar patients in delhi. | sera from 164 patients with parasitologically confirmed kala-azar and 100 patients with non-kala-azar delhite in 2 delhi hospitals were tested for anti-human immunodeficiency (anti-hiv) and anti-hepatitis c virus (anti-hcv) antibodies and hepatitis b surface antigens to determine which group is more likely to contract these infections. the mean age of the patients was 32.5 y (+/-6.5 y), (120 m, 44 f). two patients were from nepal and the others from the kala-azar endemic state of bihar, india. a ... | 2000 | 10716069 |
| hepatitis b and c viral infections in indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study. | human immunodeficiency virus (hiv) and hepatitis b and hepatitis c viruses have emerged as major blood-borne infections. several cases of infections through the use of unsterile injection needles also are on record. kala-azar, or visceral leishmaniasis, is a hemoparasitic disease caused by leishmania donovani. all the anti-kala-azar medications require multiple intramuscular injections of the anti-leishmanial drugs. to find whether these patients were at higher risk of contracting blood-borne in ... | 2000 | 11231183 |